Drug Type Small molecule drug |
Synonyms DN 1406131, DN-131, DN131 + [1] |
Target |
Action inhibitors |
Mechanism IDO1 inhibitors(Indoleamine 2,3-dioxygenase inhibitors), TDO inhibitors(Tryptophan 2,3-dioxygenase inhibitors) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 07 Sep 2018 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 07 Sep 2018 | |
| Locally Advanced Lung Non-Small Cell Carcinoma | Phase 1 | China | 07 Sep 2018 | |
| Locally Advanced Lung Non-Small Cell Carcinoma | Phase 1 | China | 07 Sep 2018 | |
| Locally Advanced Melanoma | Phase 1 | China | 07 Sep 2018 | |
| Locally Advanced Melanoma | Phase 1 | China | 07 Sep 2018 | |
| Metastatic melanoma | Phase 1 | China | 07 Sep 2018 | |
| Metastatic melanoma | Phase 1 | China | 07 Sep 2018 |





